{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:09:54Z","timestamp":1789852194485,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Cancer Research Institute, Kanazawa University"},{"name":"the Institute for Genetic Medicine, Hokkaido University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12977-015-0225-x","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T02:26:10Z","timestamp":1448331970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia"],"prefix":"10.1186","volume":"12","author":[{"given":"Naoyoshi","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haorile","family":"Chagan-Yasutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Maenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Uede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"225_CR1","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014;15:e517\u201326.","journal-title":"Lancet Oncol."},{"key":"225_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79:428\u201337.","journal-title":"Br J Haematol"},{"key":"225_CR3","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","volume":"30","author":"H Katsuya","year":"2012","unstructured":"Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H, Hanada S, et al. Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma. J Clin Oncol. 2012;30:1635\u201340.","journal-title":"J Clin Oncol"},{"key":"225_CR4","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1017\/S1462399409001215","volume":"11","author":"JC Morris","year":"2009","unstructured":"Morris JC, Waldmann TA. Antibody-based therapy of leukaemia. Expert Rev Mol Med. 2009;11:e29.","journal-title":"Expert Rev Mol Med"},{"key":"225_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2133.2004.06274.x","volume":"152","author":"T Yamaguchi","year":"2005","unstructured":"Yamaguchi T, Ohshima K, Karube K, Tutiya T, Kawano R, Suefuji H, et al. Clinicopathological features of cutaneous lesions of adult T-cell leukaemia\/lymphoma. Br J Dermatol. 2005;152:76\u201381.","journal-title":"Br J Dermatol"},{"key":"225_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor Metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275\u201392.","journal-title":"Cell"},{"key":"225_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239\u201352.","journal-title":"Nat Rev Cancer"},{"key":"225_CR8","doi-asserted-by":"publisher","first-page":"351089","DOI":"10.1155\/2012\/351089","volume":"2012","author":"HC Chong","year":"2012","unstructured":"Chong HC, Tan CK, Huang RL, Tan NS. Matricellular proteins: a sticky affair with cancers. J Oncol. 2012;2012:351089.","journal-title":"J Oncol."},{"key":"225_CR9","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1182\/blood.V82.5.1590.1590","volume":"82","author":"T Ishikawa","year":"1993","unstructured":"Ishikawa T, Imura A, Tanaka K, Shirane H, Okuma M, Uchiyama T. E-selectin and vascular cell adhesion molecule-1 mediate adult T-cell leukemia cell adhesion to endothelial cells. Blood. 1993;82:1590\u20138.","journal-title":"Blood"},{"key":"225_CR10","first-page":"6533","volume":"54","author":"Y Furukawa","year":"1994","unstructured":"Furukawa Y, Tara M, Ohmori K, Kannagi R. Variant type of sialyl Lewis X antigen expressed on adult T cell leukemia cells is associated with skin involvement. Cancer Res. 1994;54:6533\u20138.","journal-title":"Cancer Res"},{"key":"225_CR11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ijc.2910600421","volume":"60","author":"Y Tanaka","year":"1995","unstructured":"Tanaka Y, Fukudome K, Hayashi M, Takagi S, Yoshie O. Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines. Int J Cancer. 1995;60:554\u201361.","journal-title":"Int J Cancer"},{"key":"225_CR12","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V91.10.3909","volume":"91","author":"Y Tanaka","year":"1998","unstructured":"Tanaka Y, Mine S, Figdor CG, Wake A, Hirano H, Tsukada J, et al. Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. Blood. 1998;91:3909\u201319.","journal-title":"Blood"},{"key":"225_CR13","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1084\/jem.183.5.2185","volume":"183","author":"A Imura","year":"1996","unstructured":"Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, et al. The human OX40\/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med. 1996;183:2185\u201395.","journal-title":"J Exp Med"},{"key":"225_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yexcr.2011.10.012","volume":"318","author":"N Mukaida","year":"2012","unstructured":"Mukaida N, Baba T. Chemokines in tumor development and progression. Exp Cell Res. 2012;318:95\u2013102.","journal-title":"Exp Cell Res"},{"key":"225_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673\u201387.","journal-title":"Cell"},{"key":"225_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"225_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1006\/viro.1993.1656","volume":"197","author":"S Dhawan","year":"1993","unstructured":"Dhawan S, Weeks BS, Abbasi F, Gralnick HR, Notkins AL, Klotman ME, et al. Increased expression of \u03b14\u03b21 and \u03b15\u03b21 integrins on HTLV-I-infected lymphocytes. Virology. 1993;197:778\u201381.","journal-title":"Virology"},{"key":"225_CR18","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.158.8.3822","volume":"158","author":"Y Tanaka","year":"1997","unstructured":"Tanaka Y, Wake A, Horgan KJ, Murakami S, Aso M, Saito K, et al. Distinct phenotype of leukemic T cells with various tissue tropisms. J Immunol. 1997;158:3822\u20139.","journal-title":"J Immunol."},{"key":"225_CR19","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.161.6.3087","volume":"161","author":"H Hasegawa","year":"1998","unstructured":"Hasegawa H, Nomura T, Kishimoto K, Yanagisawa K, Fujita S. SFA-1\/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with \u03b15\u03b21 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin. J Immunol. 1998;161:3087\u201395.","journal-title":"J Immunol."},{"key":"225_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1023\/A:1020507828066","volume":"19","author":"H Chen","year":"1999","unstructured":"Chen H, Hori T, Maeda M, Uchiyama T. Identification of an adhesion molecule expressed on adult T cell leukemia cells derived from a patient with gastrointestinal involvement: implication for a possible role of integrin \u03b27 in leukemic cell infiltration into intestinal mucosa. J Clin Immunol. 1999;19:186\u201393.","journal-title":"J Clin Immunol"},{"key":"225_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1440-1827.2011.02649.x","volume":"61","author":"T Uede","year":"2011","unstructured":"Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int. 2011;61:265\u201380.","journal-title":"Pathol Int"},{"key":"225_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1517\/14728222.2014.925447","volume":"18","author":"M Bandopadhyay","year":"2014","unstructured":"Bandopadhyay M, Bulbule A, Butti R, Chakraborty G, Ghorpade P, Ghosh P, et al. Osteopontin as a therapeutic target for cancer. Expert Opin Ther Targets. 2014;18:883\u201395.","journal-title":"Expert Opin Ther Targets."},{"key":"225_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","volume":"16","author":"H Rangaswami","year":"2006","unstructured":"Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 2006;16:79\u201387.","journal-title":"Trends Cell Biol"},{"key":"225_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10555-007-9104-9","volume":"27","author":"PY Wai","year":"2008","unstructured":"Wai PY, Kuo PC. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev. 2008;27:103\u201318.","journal-title":"Cancer Metastasis Rev"},{"key":"225_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/sj.bjc.6605834","volume":"103","author":"GF Weber","year":"2010","unstructured":"Weber GF, Lett GS, Haubein NC. Osteopontin is a marker for cancer aggressiveness and patient survival. Br J Cancer. 2010;103:861\u20139.","journal-title":"Br J Cancer"},{"key":"225_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.leukres.2011.05.011","volume":"35","author":"H Chagan-Yasutan","year":"2011","unstructured":"Chagan-Yasutan H, Tsukasaki K, Takahashi Y, Oguma S, Harigae H, Ishii N, et al. Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia. Leuk Res. 2011;35:1484\u201390.","journal-title":"Leuk Res"},{"key":"225_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cell.2008.04.045","volume":"133","author":"SS McAllister","year":"2008","unstructured":"McAllister SS, Gifford AM, Greiner AL, Kelleher SP, Saelzler MP, Ince TA, et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell. 2008;133:994\u20131005.","journal-title":"Cell"},{"key":"225_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1172\/JCI43757","volume":"121","author":"M Elkabets","year":"2011","unstructured":"Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, et al. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest. 2011;121:784\u201399.","journal-title":"J Clin Invest."},{"key":"225_CR29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00109-014-1183-9","volume":"92","author":"D Ota","year":"2014","unstructured":"Ota D, Kanayama M, Matsui Y, Ito K, Maeda N, Kutomi G, et al. Tumor-\u03b19\u03b21 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts. J Mol Med. 2014;92:1271\u201381.","journal-title":"J Mol Med"},{"key":"225_CR30","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/\u03b3cnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175\u201382.","journal-title":"Blood"},{"key":"225_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/0300985810370009","volume":"47","author":"B Zimmerman","year":"2010","unstructured":"Zimmerman B, Niewiesk S, Lairmore MD. Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma. Vet Pathol. 2010;47:677\u201389.","journal-title":"Vet Pathol"},{"key":"225_CR32","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1128\/JVI.77.9.5286-5294.2003","volume":"77","author":"MZ Dewan","year":"2003","unstructured":"Dewan MZ, Terashima K, Taruishi M, Hasegawa H, Ito M, Tanaka Y, et al. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID\/\u03b3cnull mice: suppression by an inhibitor against NF-\u03baB. J Virol. 2003;77:5286\u201394.","journal-title":"J Virol"},{"key":"225_CR33","doi-asserted-by":"publisher","first-page":"11958","DOI":"10.1128\/JVI.01149-08","volume":"82","author":"MZ Dewan","year":"2008","unstructured":"Dewan MZ, Takamatsu N, Hidaka T, Hatakeyama K, Nakahata S, Fujisawa J, et al. Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo. J Virol. 2008;82:11958\u201363.","journal-title":"J Virol"},{"key":"225_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1359\/jbmr.1998.13.7.1101","volume":"13","author":"SR Rittling","year":"1998","unstructured":"Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res. 1998;13:1101\u201311.","journal-title":"J Bone Miner Res"},{"key":"225_CR35","first-page":"2360","volume":"93","author":"N Mori","year":"1999","unstructured":"Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, et al. Constitutive activation of NF-\u03baB in primary adult T-cell leukemia cells. Blood. 1999;93:2360\u20138.","journal-title":"Blood"},{"key":"225_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ijc.20007","volume":"109","author":"S Takeda","year":"2004","unstructured":"Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004;109:559\u201367.","journal-title":"Int J Cancer"},{"key":"225_CR37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.leukres.2009.08.028","volume":"34","author":"J Zhang","year":"2010","unstructured":"Zhang J, Yamada O, Matsushita Y, Chagan-Yasutan H, Hattori T. Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein. Leuk Res. 2010;34:763\u20138.","journal-title":"Leuk Res"},{"key":"225_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C","volume":"78","author":"AB Tuck","year":"2000","unstructured":"Tuck AB, Elliott BE, Hota C, Tremblay E, Chambers AF. Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J Cell Biochem. 2000;78:465\u201375.","journal-title":"J Cell Biochem"},{"key":"225_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/carcin\/bgp289","volume":"31","author":"R Behera","year":"2010","unstructured":"Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. Activation of JAK2\/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis. 2010;31:192\u2013200.","journal-title":"Carcinogenesis"},{"key":"225_CR40","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/onc.2013.184","volume":"33","author":"S Kale","year":"2014","unstructured":"Kale S, Raja R, Thorat D, Soundararajan G, Patil TV, Kundu GC. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via \u03b19\u03b21 integrin. Oncogene. 2014;33:2295\u2013306.","journal-title":"Oncogene"},{"key":"225_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/19336918.2015.1008332","volume":"9","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Akatsuka T, Imanaka-Yoshida K. Tenascin-C and integrins in cancer. Cell Adh Migr. 2015;9:96\u2013104.","journal-title":"Cell Adh Migr."},{"key":"225_CR42","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","volume":"68","author":"LF Lau","year":"2011","unstructured":"Lau LF. CCN1\/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci. 2011;68:3149\u201363.","journal-title":"Cell Mol Life Sci"},{"key":"225_CR43","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00018-009-0013-7","volume":"66","author":"K Ruan","year":"2009","unstructured":"Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci. 2009;66:2219\u201330.","journal-title":"Cell Mol Life Sci"},{"key":"225_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.virol.2011.02.021","volume":"413","author":"J Zhang","year":"2011","unstructured":"Zhang J, Yamada O, Kida S, Matsushita Y, Yamaoka S, Chagan-Yasutan H, et al. Identification of CD44 as a downstream target of noncanonical NF-\u03baB pathway activated by human T-cell leukemia virus type 1-encoded Tax protein. Virology. 2011;413:244\u201352.","journal-title":"Virology"},{"key":"225_CR45","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10549-011-1691-z","volume":"130","author":"JM Baek","year":"2011","unstructured":"Baek JM, Jin Q, Ensor J, Boulbes DR, Esteva FJ. Serum CD44 levels and overall survival in patients with HER2-positive breast cancer. Breast Cancer Res Treat. 2011;130:1029\u201336.","journal-title":"Breast Cancer Res Treat"},{"key":"225_CR46","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1111\/j.1582-4934.2010.01115.x","volume":"14","author":"PH Anborgh","year":"2010","unstructured":"Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med. 2010;14:2037\u201344.","journal-title":"J Cell Mol Med"},{"key":"225_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrc1477","volume":"4","author":"MM Mueller","year":"2004","unstructured":"Mueller MM, Fusenig NE. Friends or foes\u2014bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4:839\u201349.","journal-title":"Nat Rev Cancer"},{"key":"225_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392\u2013401.","journal-title":"Nat Rev Cancer"},{"key":"225_CR49","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.yexcr.2010.04.032","volume":"316","author":"K R\u00e4s\u00e4nen","year":"2010","unstructured":"R\u00e4s\u00e4nen K, Vaheri A. Activation of fibroblasts in cancer stroma. Exp Cell Res. 2010;316:2713\u201322.","journal-title":"Exp Cell Res"},{"key":"225_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/107999003321829971","volume":"23","author":"X Li","year":"2003","unstructured":"Li X, O\u2019Regan AW, Berman JS. IFN-\u03b3 induction of osteopontin expression in human monocytoid cells. J Interferon Cytokine Res. 2003;23:259\u201365.","journal-title":"J Interferon Cytokine Res"},{"key":"225_CR51","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0002-9440(10)65330-8","volume":"154","author":"XQ Yu","year":"1999","unstructured":"Yu XQ, Fan JM, Nikolic-Paterson DJ, Yang N, Mu W, Pichler R, et al. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol. 1999;154:833\u201341.","journal-title":"Am J Pathol"},{"key":"225_CR52","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1074\/jbc.M005955200","volume":"276","author":"X Shi","year":"2001","unstructured":"Shi X, Bai S, Li L, Cao X. Hoxa-9 represses transforming growth factor-\u03b2-induced osteopontin gene transcription. J Biol Chem. 2001;276:850\u20135.","journal-title":"J Biol Chem"},{"key":"225_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.archoralbio.2009.12.003","volume":"55","author":"R Kaomongkolgit","year":"2010","unstructured":"Kaomongkolgit R, Manokawinchoke J, Sanchavanakit N, Pavasant P, Sumrejkanchanakij P. Fibronectin supports TNF-\u03b1-induced osteopontin expression through \u03b21 integrin and ERK in HN-22 cells. Arch Oral Biol. 2010;55:101\u20137.","journal-title":"Arch Oral Biol"},{"key":"225_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","volume":"33","author":"B Ruffell","year":"2012","unstructured":"Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012;33:119\u201326.","journal-title":"Trends Immunol"},{"key":"225_CR55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4161\/cbt.10.2.12160","volume":"10","author":"HP Hsu","year":"2010","unstructured":"Hsu HP, Shan YS, Lai MD, Lin PW. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival. Cancer Biol Ther. 2010;10:144\u201354.","journal-title":"Cancer Biol Ther"},{"key":"225_CR56","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1007\/s00268-010-0582-5","volume":"34","author":"M Imano","year":"2010","unstructured":"Imano M, Okuno K, Itoh T, Ishimaru E, Satou T, Shiozaki H. Increased osteopontin-positive macrophage expression in colorectal cancer stroma with synchronous liver metastasis. World J Surg. 2010;34:1930\u20136.","journal-title":"World J Surg"},{"key":"225_CR57","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, et al. Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med. 2010;362:875\u201385.","journal-title":"N Engl J Med"},{"key":"225_CR58","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.4049\/jimmunol.1402103","volume":"195","author":"C Nishime","year":"2015","unstructured":"Nishime C, Kawai K, Yamamoto T, Katano I, Monnai M, Goda N, et al. Innate response to human cancer cells with or without IL-2 receptor common \u03b3-chain function in NOD background mice lacking adaptive immunity. J Immunol. 2015;195:1883\u201390.","journal-title":"J Immunol."},{"key":"225_CR59","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.3390\/cancers3043740","volume":"3","author":"M Liguori","year":"2011","unstructured":"Liguori M, Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma. Cancers. 2011;3:3740\u201361.","journal-title":"Cancers"},{"key":"225_CR60","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00262-009-0754-z","volume":"59","author":"J Dai","year":"2010","unstructured":"Dai J, Li B, Shi J, Peng L, Zhang D, Qian W, et al. A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunol Immunother. 2010;59:355\u201366.","journal-title":"Cancer Immunol Immunother"},{"key":"225_CR61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1756-9966-31-26","volume":"31","author":"F Shojaei","year":"2012","unstructured":"Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, et al. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer. J Exp Clin Cancer Res. 2012;31:26.","journal-title":"J Exp Clin Cancer Res."},{"key":"225_CR62","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00262-003-0494-4","volume":"53","author":"KH Heider","year":"2004","unstructured":"Heider KH, Kuthan H, Stehle G, Munzert G. CD44v6: a target for antibody-based cancer therapy. Cancer Immunol Immunother. 2004;53:567\u201379.","journal-title":"Cancer Immunol Immunother"},{"key":"225_CR63","first-page":"219","volume":"59","author":"YU Katagiri","year":"1999","unstructured":"Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, et al. CD44 variants but not CD44\u00a0s cooperate with \u03b21-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 1999;59:219\u201326.","journal-title":"Cancer Res"},{"key":"225_CR64","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.radonc.2011.10.013","volume":"102","author":"K Gurtner","year":"2012","unstructured":"Gurtner K, Hessel F, Eicheler W, D\u00f6rfler A, Zips D, Heider KH, et al. Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo. Radiother Oncol. 2012;102:444\u20139.","journal-title":"Radiother Oncol"},{"key":"225_CR65","first-page":"3625","volume":"9","author":"T Ishida","year":"2003","unstructured":"Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res. 2003;9:3625\u201334.","journal-title":"Clin Cancer Res"},{"key":"225_CR66","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00262-008-0632-0","volume":"58","author":"A Ito","year":"2009","unstructured":"Ito A, Ishida T, Yano H, Inagaki A, Suzuki S, Sato F, et al. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD\/Shi-scid,IL-2R\u03b3null mouse model. Cancer Immunol Immunother. 2009;58:1195\u2013206.","journal-title":"Cancer Immunol Immunother"},{"key":"225_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12185-011-0941-5","volume":"94","author":"T Ishida","year":"2011","unstructured":"Ishida T, Ueda R. Antibody therapy for adult T-cell leukemia-lymphoma. Int J Hematol. 2011;94:443\u201352.","journal-title":"Int J Hematol"},{"key":"225_CR68","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/carcin\/bgr009","volume":"32","author":"Z Mi","year":"2011","unstructured":"Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis. 2011;32:477\u201387.","journal-title":"Carcinogenesis"},{"key":"225_CR69","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.4049\/jimmunol.181.9.6384","volume":"181","author":"Y Wu","year":"2008","unstructured":"Wu Y, Li YY, Matsushima K, Baba T, Mukaida N. CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J Immunol. 2008;181:6384\u201393.","journal-title":"J Immunol."}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0225-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-015-0225-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0225-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0225-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T13:56:23Z","timestamp":1748699783000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-015-0225-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["225"],"URL":"https:\/\/doi.org\/10.1186\/s12977-015-0225-x","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]},"assertion":[{"value":"12 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"99"}}